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Abstract
The overall picture of health in sub-Saharan Africa can easily be painted in dark colours. The aim of
this viewpoint is to discuss epidemiological data from Tanzania on overall health indicators and the
burden of malaria and HIV. Is the situation in Tanzania improving or deteriorating? Are the
health-related millennium development goals (MDG) on reducing under-ﬁve mortality, reducing
maternal mortality and halting HIV and malaria within reach?
Conclusion: Child mortality and infant mortality rates are decreasing quite dramatically. Malaria prevention
strategies and new effective treatment are being launched. The MDG 4 on child mortality is clearly within reach,
and the same optimism may apply to MDG 6 on combating malaria.
The African continent encompasses the six countries where
life expectancy at birth is 40 years or less, and all coun-
tries (with the exception of Afghanistan) that is around 30,
wherelifeexpectancyatbirthisbelow55years(1).Although
the continent hosts countries as different from one another
as South Africa and Egypt or Sudan and Malawi, the over-
all picture of health in Africa can easily be painted in dark
colours. The demographic burden of the HIV-epidemic is yet
to add its full weight to the picture.
Many African countries have been struck by war and po-
litical instability, which makes the judgement of the perfor-
mances of the health systems even more difficult. Tanzania
is an interesting country to observe, as it has had a peace-
ful development following independence in 1961. Also, it has
beensubjecttodecadesofaidprojectsattemptingtoimprove
health on various levels.
The country is currently undergoing a transition from a
one-party-state with a socialist economy to a multiparty
democratic system with a market economy. Tanzania re-
ported an annual growth rate of 6.7% (2) in 2004, which
exceeds that of most Western countries. The growth is how-
ever taking place from a level just a little over a hundredth
of the GNP-levels of the rich European countries, with 58%
of Tanzanians living below the poverty line, with an income
of less than 1 USD a day (3). Fertility rates in Tanzania have
seen just a slight decline (4) and are still very high, with
5.7 children born to each woman (5). Since independence,
the population of Tanzania has quadrupled (Table 1) (6,7)
(Table 1).
INDICATORS ON CHILD MORTALITY CLEARLY BETTER
Mortality rates and causes of death are far from reliable in
manysub-Saharancountries,andWHOhasjudgedonlyfour
African countries to produce useable data (9). Statistics may
be lacking totally or be marred by great imperfections on
all levels; in describing populations, in registration of deaths
outside facilities, in correct diagnosis of deaths and in han-
dling of data once registered.
To make up for the lack of high-quality national registers
of vital events, such as births and deaths, other approaches
are used. These various sources of information aid organi-
zations like the World Health Organization (WHO) and the
World Bank in modelling the national estimations that will
determine for example a nation’s success or failure in fulfill-
ing the millennium development goals (MDG).
Sentinel surveillance is an approach where carefully se-
lected sites are monitored, for example to get an estimate of
the burden of disease, such as the prevalence of HIV-positive
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women in a certain antenatal clinic. To pool data from
sentinel sites to produce national estimates may or may not
be relevant. Longitudinal surveys or demographic surveil-
lance, where vital events in a certain area are prospectively
recorded and explored during a period of time, will have ad-
vantages in accuracy but be limited to the area they cover.
In direct surveys information about vital events is recorded
retrospectively, usually by interviews. Here, the selection of
respondents and their ability to correctly remember for ex-
ample dates of birth and ages at death will be crucial for the
quality of data.
In a large Demographic Surveillance Systems (DSS) in
Tanzania three different geographical regions have been
followed between 1992–1997 (AMMP-1) and 1999–2004
(AMMP-2). The great advantage of this study is that the
researchers used a community-based approach covering
450 000 persons and more than 50 000 households with
deaths were visited by enumerators performing verbal au-
topsies (10). This survey was a collaboration between the
Tanzanian Ministry of Health and the University of
Newcastle upon Tyne. It is likely to be one of the more
reliable sources of information on causes of death avail-
able, together with the longitudinal surveys performed by
the Ifakara Health Research and Development Centre (11).
In AMMP, the infant mortality rate in 1994–1999 ranged
from 74/1000 live born children to 131/1000 in the three
regions investigated. In 1999–2002 the infant mortality rate
had dropped to a range of 65/1000 in the best to 116/1000
in the worst of the three regions. A decrease in under-five
mortality was also seen with the best of the three regions
going from 103/1000 live born children in 1994–1999 to 88
in 1999–2002. In the region having the highest under-five
mortality rate it dropped from 209/1000 to 185/1000 in the
same period.
The 2004–2005 Tanzania Demographic and Health Sur-
vey (THDS) by the Tanzanian National Bureau of Statistics
Table 1 A comparison on statistics for Sweden and Tanzania. In Tanzania, the public expenditure on health is 2.4% of the GNP (7), or 7.6 USD per person and
year. With the addition of external resources from donors it is estimated that a total of 10 USD per year is spent on all health care for each person (7,8)
Population Population Income per Public health Under-ﬁve mortality Maternal mortality
1961 (millions) 2005 (millions) capita 2004 expenditure (per cent (per 1000 live 2000 (per 100 000
(5) (6) (USD) (6) of GDP) (6) born) 2004 live births)
Tanzania 10 38 320 2.4 112 (5) 578 (5)
Sweden 7,5 9 35 480 8 4 (6) 2 (6)
Ratio Tanzania to Sweden 1.3 4.2 0.01 0.3 28 290
Table 2 Millennium Development Goals on child and maternal mortality rates. Wrestling with clearly disparate data on maternal deaths, the MDG-evaluators in
2015 will have a hard time trying to determine if Tanzania has been able to reduce maternal mortality by 75% from the level in 1990. Ironically, it seems that the
most ambitious MDG on maternal deaths currently must face statistics that are not clearly improving at all. The child mortality goal is clearly within reach but a
focus on neonatal and infant mortality is needed
Millennium Development Goal Tanzania in 1990 (3) 2000 (3) 2004 (5) Goal for 2015 (3)
Goal 4 reduce under-ﬁve mortality by 66% 161 141 112 54
(deaths before 5 years/1000 live born)
Goal 5 reduce maternal mortality rate by 75% 770 1500 578 192
(Maternal deaths/100.000 live births)
and Macro International was designed to produce national
estimates on health-related issues (5). A representative sam-
ple of 10 312 households was selected and all women aged
15–49 in these households were interviewed, as was a sub
sample of men. This survey is the sixth in a series of national
sample surveys and considered reliable.
The 2004–2005 THDS found a further decrease in recent
years to 68/1000 for infant mortality rate and 112/1000 for
under-five mortality rate (5).
A striking geographic variation in under-five mortality,
also when comparing very rural regions, was demonstrated.
In this survey weight and height in children were recorded
and poor nutritional status had a strong correlation with the
risk of child death. The fit was surprisingly poor between
childhood death and general poverty in the region (12). Re-
cently, a study from the southern parts of Tanzania, where
the mortality rates are by far the highest, has explored the
local attitudes, recognition and perception of sick children.
It seems reasonable to assume that local practices and atti-
tudes to severe disease influence mortality to a great extent
(13).
Regardless of source, all statistics on child death repre-
sent improvements (Table 1) and the MDG may be within
reach for the indicator childhood mortality (Table 2). For
this to happen, a focus on reducing infant mortality that con-
tributes more than half of the under-five mortality is needed.
Neonatal mortality, in turn, constitutes almost half of the in-
fant mortality; with 32 children out of 1000 live born dying
within the first month. Neonatal mortality is of course con-
nected to maternal mortality, and it is important to stress
that neonatal mortality has remained unchanged, whereas
infant mortality has decreased at a similar pace, or slightly
faster, than under-five mortality during the last decade.
Clearly, more focus on neonatal and infant survival is
needed. To reduce the risk of maternal anaemia and malaria,
pregnant women are currently treated for malaria twice in
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the pregnancy and this treatment currently reaches just over
half of all pregnant women. Eight in ten pregnant women
have at least one tetanus-vaccination. In Tanzania, less than
half of all women, 46%, have a skilled person assisting when
giving birth, 53% of women deliver at home and over 80%
of them do not come for a postnatal check-up. Half of all
children are not weighed at birth. Vaccination coverage is
unchanged over the last years with 71% of children receiv-
ing all recommended vaccination. Knowledge about oral re-
hydration salt (ORS) is high but only half of children with
diarrhoea received ORS-packages (5). All of these aspects,
and many more, need to be addressed to reduce neonatal
and infant mortality further.
MATERNAL MORTALITY SUCCESSFULLY ADDRESSED IN KIGOMA
Maternal mortality ratios are generally believed to be more
powerful tools in evaluating the performance of the health
sector. To prevent a maternal death puts higher demands on
structures such as screening and integrated referral systems,
whereas child mortality at a high level can be reduced with
relatively simple means such as immunizations.
But, in contrast to the child mortality rates, the official ma-
ternal mortality rate in Tanzania is increasing. In the WHO
MDG-statistics, Tanzania shows a very alarming increase in
maternal deaths, from 770 mothers per 100 000 live births in
1990 to 1100/100 000 live births in 1995 and 1500/100 000
in 2000 (Table 2) (3).
However, the same DSS as cited above shows mater-
nal death rates that are lower, with maternal mortality in
2001 ranging from 570/100 000 in the second best region
to 718/100 000 in the worst region which in this case is the
capital (10). The data from the region with the lowest figure
is not shown here, as it is marred by one area reporting no
maternal deaths in the poorest quartile of the population.
A large study compared different methods for assessing
maternal deaths in northwest Tanzania using three tools: a
prospective community based survey; a sisterhood survey
where respondents were asked about deaths among their
Figure 1 Child survival rates in Tanzania continue to improve and under-ﬁve
mortality has fallen by one-third since 1990. ‘Afya’ means health in Swahili.
Figure 2 Malaria is contributing to a large share of deaths in infants and young
children.Thepictureshowsrapidtestingformalariawithadirectdipstickmethod
that requires neither electricity nor a laboratory technician.
adult sisters, and a hospital survey (14). This study, per-
formed 1986–1991, came to the conclusion that hospital
data tend to overestimate maternal deaths by a factor of
three.Hospitalswerereportingamaternaldeathrateof845/
100 000, whereas in the prospective study and sisterhood
survey, the figures were 241 and 297, respectively.
In another and more recent study in northern Tanzania
in 1995–1996, the reverse, a clear underestimation of deaths
in pregnant women was shown with a majority of hospi-
tal deaths in pregnant women not being recorded properly.
Nevertheless,thisstudyestimatedtheoverallmaternaldeath
rate to be 382/100 000 (15). A sisterhood survey showed a
similar figure of 362 (16).
In the 2004–2005 THDS the maternal mortality rate was
estimated to be 578/100 000 live births (5) (Table 2). This
represents a non-significant change from the previous survey
in 1996 and its estimate of 529.
Some of the most interesting studies of maternal mortality
in Tanzania have been performed in the Kigoma region, a
remote area bordering the Republic of Congo and Burundi.
Following a retrospective study carried out in 1984–1986 a
programmewith22specificinterventionswasundertakenin
1987–1991. In this period the calculated maternal mortality
ratio decreased from 933 to 186 per 100 000 live births, with
the actual number of maternal deaths being 28 deaths in
1984 and eight deaths in 1991. This illustrates that a low-cost
intervention programme can be very successful (17,18).
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MALARIA, HIGH TIME TO ROLL BACK?
Man and malaria have walked hand-in-hand throughout
evolution. The forceful genetic selection pressure of a dis-
ease that is most prone to kill infants and young people be-
fore reproductive age has had obvious effect on the global
distribution of blood-groups and prevalence of diseases such
as sickle-cell anaemia that make the individual less suscep-
tible to malaria.
Malaria is becoming an increasingly important global
health problem. The disease is causing more deaths in the
world than before and is responsible for a larger fraction
of deaths, mainly due to resistance to previously successful
drugs (19,20). Although the contribution of acute or chronic
malaria to deaths in HIV/AIDS-patients is likely to repre-
sent a growing problem, malaria alone probably remains
Africa’s number one child killer. The figure often cited is
that malaria causes 1 million deaths per year in the world,
or 3000 deaths a day. Ninety percent of these deaths occur
in Africa, and almost all of the diseased are children (20).
The period of eradication of malaria with intensive use of
insecticides for vector control that helped clear parts of the
world from malaria is long gone, though some argue that
insecticides such as DDT must be used again. The WHO
issued guidelines in 2006 stating that DDT could be used
in restricted conditions (21), and the Ugandan government
announced recently that they would use the insecticide to
fight malaria (22).
There are promising observations from the island of
Zanzibar, part of the United Republic of Tanzania, that
malaria incidence has decreased substantially during the last
years. Modern vector control, primarily the use of impreg-
nated bed nets and in-door spraying, efficient treatment with
artemisinin-based compounds and community involvement
has assisted in this work, and the village of Jambiani on
Zanzibar is now becoming a model of malaria control (23).
The new artemisinin-based compounds used for treating
malaria are efficient, both for the treated individual and by
reducing the parasite gametocyte formation and thereby re-
ducing transmission to others. In Zanzibar, artesunate taken
together with amodiaquine has been first line drug since
2002. In mainland Tanzania artemisinin in the combination
therapy artemether-lumefantrine (Coartem) was decided to
be first line therapy from November 2006 (24), and the in-
troduction has been quite efficient with Coartem now being
available also in rural facilities (January 2007).
A major problem with the new drugs, currently the global
hope for treating malaria parasites that have developed re-
sistance to earlier drugs, is the high cost. One single treat-
ment of an adult with Coartem bought over-the-counter in
the capital is 10 000 Tanzanian shillings (7.5 USD), the full
annual government spending on health care for one person,
or the equivalent of 20 kg of maize flour used for cooking
the staple food ugali.1
In Tanzania, malaria is often diagnosed clinically. Treat-
ments are often bought by the patient with little or no
1 Market price at private pharmacy close to Muhimbili University
HospitalinDaresSalaamOct2006andneighbouringgroceryshop.
involvement of trained health personnel. Also, means of
correct diagnosis are quite limited at health facilities. In
Tanzania, less than 5% of rural households have electricity,
and the typical rural dispensary has no electricity. Sun-lit mi-
croscopes are an option though not widely used, and still de-
mand trained technicians for slide reading. Even if available,
the quality of the test can be questioned by the clinicians and
results are not always considered (25,26). New rapid diag-
nostic tests that are based on antigen-reactions and require
neither microscope nor electricity are very promising but ex-
pensive.
In the chloroquine-era, high incidence of malaria, poor
means of diagnostics, risk of fatal outcome and efficient
and cheap treatment were good arguments for treating most
fevers as malaria, especially if the patient was a child. The In-
tegrated Management of Childhood Disease (IMCI) guide-
lines still instructs that all fevers in under-fives in endemic
areas are treated as malaria.
In adults, however, malaria is not always the explanation
for fever, and previous experience and social acceptance of
malariaasacauseoffeverhascontributedtoextensiveuseof
antimalarials. In a large and prospective study evaluating the
size of this problem, overdiagnosis by two-fold was demon-
strated for a district hospital setting and higher mortality
was shown for patients that were false positive for malaria
(25). Overdiagnosis of malaria is causing unnecessary costs,
steering attention away from other important killer-diseases
such as childhood pneumonia (27) and contributing to drug
pressureanddevelopmentofresistancetowardsantimalarial
drugs. The overdiagnosis naturally also reflects on malaria
mortality rates statistics, but it is not known to what extent.
For example, in the SPP cited above, malaria is included in
the term ‘acute febrile illness’.
So, on one hand the global burden of malaria is clearly in-
creasing, and on the other, its overdiagnosis is a big problem
both for the health system and for the individual. These two
pictures are both likely to be true, and not as contradictory
as they may sound, even if the proportion of HIV/AIDS/TB
now can be expected to account for a larger share of all
fevers than before. Strategies to improve the ability to diag-
nose malaria correctly are seriously needed.
All in all, the combination of weapons; the impregnated
bed-nets, indoor spraying, the new potent drugs, now also
available for rectal administration in children unable to take
drugs orally (13) and the better diagnostic possibilities, are
likely to assist man in winning terrain and halt and reverse
the malaria, thereby fulfilling part of the MDG 6.
HIV AND AIDS: BETTER THAN FEARED?
HIV/AIDS/tuberculosis is the leading cause of death in
adults 15–59 years of both sexes in all three areas stud-
ied in the study cited above: Dar es Salaam, the rural ar-
eas around Morogoro and in the Hai district in Northern
Tanzania. Among women living in the capital aged 15–
59 years HIV/AIDS/TB accounted for 62% of the 203
deaths analyzed in this group (10). A big survey by Tanzania
Commission for Aids in 2003–2004 showed that 7%, that is
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every twelfth adult 15–59 years, is infected by HIV, with big
regional differences (28).
All reports on HIV-prevalence are marred by the low fre-
quency of testing in the general population. In spite of the
confusion surrounding the HIV situation, very interesting
dataonincidenceofinfectionhasbeencollectedfromthere-
gion west of lake Victoria. In three areas having contrasting
initial exposure to the epidemic, individuals who were sero-
negative in the baseline survey 1987 have been followed with
high response rates. The overall age-adjusted prevalence in
the high-prevalence area of Bukoba decreased from 24.2%
in 1987 to 13.3% in 1996, and the incidence in the same area
declined from 47.5 to 9.1 per 1000 person years in the years
between 1989 and 1996. That is, the risk has decreased from
one person in twenty being infected each year to one person
in a hundred. The figures are slightly better for women be-
tween the ages of 15–24 years, for whom a decreased inci-
dence was also noted in areas with middle and low initial
prevalence (29).
For treatment of AIDS, the introduction of antiretrovi-
ral therapy (ARV) is continuing in Tanzania, but ARVs are
not yet distributed in the countryside on a large scale out-
side programmes run by non-governmental and faith-based
organisations. The National AIDS Control Programme es-
timates that 49 315 Tanzanians were receiving ARVs in
September 2006, and WHO claims that 315 000 need the
drug. This coverage of 15% is quite a bit lower than in neigh-
bouring Uganda (50%) and Kenya (25%) (30).
Basic drugs like antibiotics and antimalarials in Tanzania
are distributed in the well-functioning Essential Drug Pro-
gramme to reach the government first level health facility
(village dispensary). The treatment of HIV-AIDS is still cen-
tralized, and diagnostics of HIV, eligibility for treatment by
CD4 counts and the ARVs are usually available only at the
tertiary level health facility (district hospital). Even if the
drugs are provided for free, social aspects as understand-
ing the need for treatment, risk of stigmatization and cost
for travelling makes the cumbersome and life-long AIDS-
treatment out of reach for many affected individuals in rural
areas. There is a great fear that those enrolled in treatment
will drop out once they feel better. In reality most HIV-
infected patients in Tanzania have neither correct diagno-
sis nor access to treatment and to establish these systems
with trained and educated staff is an enormous challenge for
a weak health system. A special presidential initiative sup-
ported by donors to implement and decentralize treatment
of AIDS continues.
Oftheextremelysuccessfulstrategiesthatpreventmother-
to-child HIV-transmission in the developed world (cae-
sarean section, no breast milk and ARVs) (31) only ARVs
would be useful in the rural African context. The aware-
ness in the general population of the possibility is however
low, and in the study cited above only 15% of respondents
know both that HIV can be transmitted to a child through
breast-feeding and that there are special drugs that a preg-
nant mother can take to reduce the risk of transmission (28).
The health situation and the rate of economic growth in
Tanzania are greatly affected by HIV. As has been pointed
out (32) the ability of women to use any of the components
of the abc-strategy (abstain, be faithful, use a condom) to
prevent AIDS is limited, and it has been demonstrated that
married women are at high risk of transmission. However,
the good news is that the situation may be better than feared.
The Bukoba-study shows that the most significant decline
in HIV-incidence is among women in the age group 15–
24 years (29). If these figures are correct, and assuming
the virus is as contagious and people as susceptible as be-
fore, this must reflect a change in sexual behaviour. People
can understand and make good choices, and for poor peo-
ple with little access to more sophisticated methods of pre-
vention or treatment it is especially necessary that they do
so.
NEED FOR FUTURE
Vaccines against malaria and HIV are being developed but
are not likely to assist in reaching the MDGs for 2015.
In order to fulfil the MDGs, work to improve health fur-
ther in Tanzania will need political and professional coop-
eration. Scarce resources must be spent wisely and where
they will make a difference. It is easy to waste health care
resources, more so than in many other fields targeted by de-
velopment efforts, if ‘bottle-necks’ are allowed to clog the
system, or if limiting factors such as lack of well-trained and
highly motivated staff are not urgently addressed. All com-
ponents of a functioning health care system need to be avail-
able for the system to perform well and the biggest problem
in Tanzania is probably lack of skilled staff.
It is crucial that cheap and reliable surveillance systems
are developed further, preferably community based and us-
ing modern communication techniques, such as satellite
communications from the field sites. With unreliable data, it
is hard to tell if the limited resources are spent well or should
be used elsewhere.
We are yet to see if Tanzania will be able to fulfil the MDG
by 2015 but one can be quite optimistic about reaching two
of the health-related goals: to reduce under-five mortality
by two thirds from the 1990-level, as well as halting and
reversing the incidence of malaria.
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